Crossmark

SESTD1 as a potential prognostic biomarker associated with tumor aggressiveness and immune infiltration in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2025.100796

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Liu, Ying https://orcid.org/0009-0003-5142-0494
Chen, Taoying https://orcid.org/0009-0003-6111-1871
Tang, Li https://orcid.org/0000-0002-8941-5987
Cheng, Daqing https://orcid.org/0009-0006-8081-9375
Xu, Ming https://orcid.org/0009-0005-1536-8427
Wu, Jiaoxiang https://orcid.org/0000-0002-2309-4164
Liu, Bingyan https://orcid.org/0000-0002-1459-1935
Cheng, Hao https://orcid.org/0009-0006-6315-2476
Han, Bo https://orcid.org/0000-0002-9882-7166
Zhang, Yu https://orcid.org/0000-0002-4696-2526
Cheng, Sheng https://orcid.org/0000-0001-9916-3405
Funding

Funding for this research was provided by:

Fundamental Research Funds for the Central Universities (YG2022QN117, YG2025QNB53)

National Natural Science Foundation of China (82002495)
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-09-19
More Information

This article is maintained by: Elsevier

Article Title: SESTD1 as a potential prognostic biomarker associated with tumor aggressiveness and immune infiltration in hepatocellular carcinoma

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2025.100796

Content Type: article

Copyright: © 2025 HCFMUSP. Published by Elsevier España, S.L.U.